Correction to: The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities

Affiliations

• ¹ Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Room 1106, Silver Spring, MD, 20993, USA. [email protected].
• ² Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Room 1106, Silver Spring, MD, 20993, USA.